Chemed Corporation
CHENYSEHealthcare● Active
$439.13
$-2.46(-0.56%)
Market Cap$5.8B
P/E Ratio—
52W High$562.77
52W Low$365.21
Chemed Corporation（CHE）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CHE · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.27B | $0.30B | $0.27B | $0.25B | $0.27B |
| Depreciation & Amort. | $0.06B | $0.06B | $0.06B | $0.06B | $0.06B |
| Stock-Based Comp. | $0.00B | $0.03B | $0.03B | $0.03B | $0.02B |
| Change in Working Capital | $0.02B | $0.01B | ($0.04B) | ($0.03B) | ($0.03B) |
| Net Cash from Operations | $0.39B | $0.42B | $0.33B | $0.31B | $0.31B |
| Investing Activities | |||||
| Capital Expenditure | ($0.06B) | ($0.05B) | ($0.06B) | ($0.06B) | ($0.06B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.06B) | ($0.14B) | ($0.06B) | ($0.06B) | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.43B) | ($0.36B) | ($0.07B) | ($0.11B) | ($0.58B) |
| Dividends Paid | ($0.03B) | ($0.03B) | ($0.02B) | ($0.02B) | ($0.02B) |
| Debt Issued / Repaid | $0.01B | ($0.02B) | ($0.08B) | ($0.10B) | $0.20B |
| Net Cash from Financing | ($0.43B) | ($0.36B) | ($0.08B) | ($0.21B) | ($0.38B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.33B | $0.37B | $0.27B | $0.25B | $0.25B |
| FCF Margin %(computed) | 12.86% | 15.13% | 12.08% | 11.83% | 11.68% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Chemed Corporation
关于Chemed Corporation（CHE）现金流量表
Chemed Corporation 2025财年经营活动现金流$0.39B，自由现金流$0.33B（FCF利润率12.86%），资本支出($0.06B)。
常见问题
CHE · 4 问Chemed Corporation 2025财年自由现金流$0.33B，同比down11.5%。
CHE free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10